(Reuters) – Ocugen Inc said on Friday the U.S. Food and Drug Administration has declined to issue an emergency use authorization for its partner Bharat Biotech-developed COVID-19 vaccine Covaxin for use in individuals aged 2 to 18 years.
(Reporting by Leroy Leo in Bengaluru; Editing by Aditya Soni)
